Pay bonanza for blue chip bosses: Rolls-Royce chief 'Turbo' Tufan set for £24m as GSK's Walmsley scoops £15.7m

Erginbilgic, pictured, has led a stunning turnaround, and has been rewarded with a deal that puts him on course to rival AstraZeneca chief Pascal Soriot.